Internal Medicine
| 2 min read
In a move that will expand its oncology pipeline, Biogen Idec announced the signing of a definitive merger agreement for the acquisition of Conforma Therapeutics Corp.
| 2 min read
In a recent issue of Science, researchers believe they have found a way to selectively target G protein-coupled receptors (GPCRs) with small-molecule compounds that interrupt protein-protein interactions.
| 2 min read
In a move that was perhaps equal measure protective and proactive, SRI International announced recently it has acquired all the operations of clinical pathology analysis company Quality Clinical Labs (QCL).
| 2 min read
Aureus Pharma has teamed with Budapest, Hungary-based ChemAxon; the Budapest University of Technology and Economics; and Paris-based sanofi-aventis for a project called KnowTox.
| 2 min read
Scientists at IBM Research announced recently the discovery of conserved sequence patterns within the human genome that suggest biological functions for DNA previously thought to represent dead areas between genes—the so-called junk DNA.
| 2 min read
I don’t care who you are—man or woman, adult or child—everyone is intrigued by dinosaurs.
| 3 min read
This month, Jeffrey Bouley takes a look at some of the potential issues that could provide complications for the disbursement of funds by the California Institute for Regenerative Medicine (CIRM), the body created with the passage of Proposition 71 in 2004 which provided $3 billion in state funds for embryonic stem cell research (see editconnect E050605). Apparently some folks have been stirring the pot of foment by questioning both the potential royalties schedule faced by researchers
| 1 min read
To determine intestinal absorption of drug candidates, researchers often rely on in vitro assays
